US Biotech Hubs for International Scientists on OPT and H-1B: Boston, Bay Area, San Diego and More
Boston, the Bay Area, San Diego, Maryland and the Research Triangle compared by H-1B filers and cap-exempt labs, so you can pick a biotech hub that fits your visa clock.

The main biotech hubs in the USA for international scientists are Boston-Cambridge, the San Francisco Bay Area, San Diego, Maryland's I-270 corridor, Princeton and central New Jersey, the Research Triangle around Durham, and Philadelphia. If you are on OPT, STEM OPT or H-1B, compare them by employer mix, not lab count. Cap-exempt universities, nonprofit research institutes and government research labs can sponsor an H-1B at any time of year without the lottery, while biotech and pharma companies need a lottery selection first. As of November 1, 2026, those cap-exemption rules are in effect and unchanged.
Status, as of 2026-11-01:
- Cap exemptions: in effect (8 CFR 214.2(h)(8)(iii)(F), revised 2025-01-17). A USCIS draft rule titled "Reforming the H-1B Nonimmigrant Visa Classification Program" (RIN 1615-AD00) has been under OIRA review since 2026-08-24; its agenda abstract lists "revising eligibility for cap exemptions." No text is public, and nothing has changed.
- Proclamation 11069: in effect on paper; the $100,000 payment is blocked. The proclamation runs to 2027-09-21, but federal courts have vacated the agency policies that implement the payment, so it is not being collected. The USCIS I-129 page (updated 2026-10-30) says that if that order is lifted, "DHS still plans to collect the payment."
- Lottery: wage-weighted selection in effect since 2026-02-27; FY2028 registration not announced.
- OPT: the 90-day unemployment limit (150 days on STEM OPT) and the STEM OPT 180-day automatic extension are in effect.
Top biotech hubs in USA for OPT and H-1B scientists, compared
For an international scientist, a biotech hub is only as strong as its sponsors. Compare the seven main US clusters on two counts: how many employers there already file H-1B petitions, and how many cap-exempt research employers (universities, affiliated hospitals, research institutes, federal labs) can hire you without the lottery. The table below does both.
Biotech hubs by H-1B filers. Employers with 25 or more H-1B petition decisions, and their total decisions, FY2024 through FY2026 (FY2026 partial), from the USCIS Employer Data Hub extract behind our company pages. Totals cover every industry.
| Hub (our data page) | Employers / decisions, all industries | Life-science filers (decisions) | Cap-exempt anchors to check |
|---|---|---|---|
| Boston-Cambridge | 133 / 18,279 | Thermo Fisher 457; Dana-Farber 322; Moderna 223; Vertex 206 + 140; Biogen 167 | Harvard, MIT, Broad Institute, Dana-Farber |
| San Francisco Bay Area | 357 / 96,313 | UCSF 645 + 102 (two filer names) | UCSF, Stanford |
| San Diego | 24 / 4,515 | Illumina 225; Dexcom 101 | UC San Diego (La Jolla), nonprofit research institutes |
| Princeton, NJ | 58 / 6,303 | Bristol Myers Squibb 530 | Princeton University |
| Maryland (statewide) | 81 / 20,047 | NIH 491; AstraZeneca 234; HHMI 123 + 121; Alexion 102 | NIH, HHMI, Johns Hopkins, University of Maryland |
| Durham, NC | 18 / 7,625 | IQVIA 323 + 117; LabCorp 218 | Duke, UNC-Chapel Hill |
| Philadelphia | 28 / 10,991 | Penn 723; CHOP 135 + 121 | Penn, CHOP |
How should you read these numbers?
They count petition decisions across every industry, not biotech jobs. USCIS says its Hub has data on "the first decisions USCIS makes on petitions for initial and continuing employment" (USCIS H-1B Employer Data Hub), so extensions for people already on staff count too. Our company pages split each year into initial and continuing approvals; the initial line is the better proxy for first-time H-1B hires.
Headline totals mislead. IBM supplies most of Durham's, Qualcomm entities most of San Diego's, Deloitte and Comcast most of Philadelphia's, Tata Consultancy Services most of Maryland's, and tech companies dominate the Bay Area's. Hubs are also built from each employer's main filing city, so Genentech (South San Francisco) and Gilead (Foster City) fall outside our Bay Area hub, and UC San Diego (La Jolla) outside the San Diego one. FY2026 is partial in our extract; the live Hub now runs through FY2026 quarter 4.
Hub by hub: what each one offers a scientist on a visa
Boston and Cambridge
Boston has the densest mix of both employer types. Universities, the Broad Institute and teaching hospitals such as Dana-Farber Cancer Institute sit a short ride from cap-subject filers such as Thermo Fisher Scientific in Waltham, Moderna and Biogen in Cambridge and Vertex in Boston, so a postdoc-then-industry path can stay in one metro. Our Boston biotech and university H-1B guide lists the area's employers by type.
San Francisco Bay Area
The Bay Area has the most filers of any hub (357 employers), mostly tech. Its life-science anchor in our hub data is UCSF, filing under two names (645 and 102 decisions); as part of the University of California, it can file cap-exempt petitions for its own employees. Stanford (1,359 decisions) is the other large university filer. Stanford, South San Francisco and Foster City all sit outside the hub's city list, so build the industry list company by company, starting with Genentech (303 decisions) and Gilead (434).
San Diego
San Diego is smaller and concentrated: 24 employers, most of the decisions from Qualcomm entities. The largest life-science filers are Illumina (225) and Dexcom (101), both cap-subject. The research anchors sit in La Jolla: UC San Diego (388 decisions) plus nonprofit institutes that may qualify as nonprofit research organizations, which you confirm with each institute. The San Diego biotech and defense H-1B guide explains why clearance-required defense work is generally closed to visa holders.
Is the Maryland I-270 corridor a real biotech hub?
Yes. From Bethesda up I-270 to Gaithersburg sit NIH (491 decisions), AstraZeneca (234) and Alexion (102), with the Howard Hughes Medical Institute in nearby Chevy Chase (123 and 121 under two filer names). Federal research agencies can qualify as government research organizations and research nonprofits as nonprofit research organizations, both cap-exempt categories; confirm with each employer. Johns Hopkins and the University of Maryland add large university filers in Baltimore. The Maryland H-1B guide separates all of them from the IT filers.
Princeton and central New Jersey
Bristol Myers Squibb leads life science in the Princeton hub (530 decisions among 58 employers); most of the other large filers are IT and finance firms. New Jersey pharma is spread across towns our data splits into small hubs, so also open the New Jersey state hub.
Research Triangle (Durham, Raleigh, Chapel Hill)
Durham's life-science filers are clinical research and lab-services companies, IQVIA (323 and 117 under two names) and LabCorp (218), which suits clinical research, biostatistics and clinical data roles. Duke and UNC-Chapel Hill are the university anchors. See the Research Triangle H-1B guide.
Philadelphia
The University of Pennsylvania is a large university filer (723 decisions), and Children's Hospital of Philadelphia files under two names (135 and 121). The Philadelphia H-1B guide covers the region's pharma employers.
Texas and Florida: check state rules first
Florida's Board of Governors paused new H-1B hires at its 12 public universities from 2026-03-02 until at least 2027-01-05; current workers and renewals are not affected (Central Florida Public Media). Texas froze new H-1B petitions at state agencies and public universities from 2026-01-27 through 2027-05-31 unless the Texas Workforce Commission gives written permission (FOX 7 Austin). Both are in effect as of 2026-11-01. Private universities, private hospitals and companies are not covered; a public university's medical center may be, so ask the institution.
Are academic research jobs in biotech hubs cap-exempt?
Often, because the employer type decides it, not the job title. USCIS's H-1B page says workers "petitioned for or employed at an institution of higher education or its affiliated or related nonprofit entities, a nonprofit research organization, or a government research organization" are not subject to the cap. What that means in practice, under the rules in effect since the 2025-01-17 revision of 8 CFR 214.2(h)(8)(iii)(F) and the cap-gap rule:
- Affiliated nonprofits can qualify through a written affiliation agreement where "a fundamental activity" supports the university's mission. Some university teaching hospitals qualify this way; a hospital without a qualifying affiliation does not, so ask HR which basis it files under.
- Placement at a qualifying entity. A worker for a non-qualifying employer is cap-exempt only if they spend at least half their time working at a qualifying entity, telework included. A university incubator address alone does not make a startup cap-exempt.
- No cap-gap. USCIS says cap-gap "applies only to beneficiaries of cap-subject H-1B petitions" (USCIS cap-gap page). See whether cap-gap applies to cap-exempt H-1Bs.
- Leaving academia. If cap-exempt employment ends, you become cap-subject unless already counted against the cap in your six-year period. You can add concurrent cap-subject work without being counted only while the cap-exempt job continues; if that job ends, USCIS "may revoke" the concurrent petition.
Some labs offer a J-1 research scholar post instead (up to five years). The two-year home-residency rule can still attach through government funding, or through the Exchange Visitor Skills List for countries still on it; the 2024-12-09 revision removed China and India. Compare the two in our J-1 vs H-1B guide for researchers.
Cap-exempt lab vs biotech company: what changes for your visa
Employer type and your H-1B, as of 2026-11-01.
| Question | Cap-exempt employer (university, affiliated nonprofit, nonprofit or government research org) | Cap-subject employer (biotech, pharma, CRO, startup) |
|---|---|---|
| Lottery needed? | No | Yes; FY2028 registration not announced; wage-weighted selection in effect |
| When can the H-1B start? | Any time of year, on the approved start date | October 1 at the earliest for a new cap case |
| Cap-gap if OPT ends first? | No | Yes, for a timely, selected petition requesting change of status: to April 1 of the fiscal year, or the petition start date if earlier |
| STEM OPT possible? | Yes, with a qualifying STEM degree, if the employer is in E-Verify and signs Form I-983 | Same |
| Later move | Next employer must be cap-exempt, or you need the lottery unless already counted | Once counted, generally not counted again in your six-year period |
| $100,000 payment | Blocked; never covered a change of status USCIS grants inside the US | Same |
USCIS's STEM OPT page (updated 2026-01-30) sets the E-Verify requirement and says that for timely filers "we will automatically extend your employment authorization for 180 days."
Do biotech startups sponsor H-1B?
Some do, but a startup petition is cap-subject unless one of the cap-exempt routes above applies. That means a lottery selection, an October 1 start for a new cap case, and a wage question: since 2026-02-27 a registration whose offered wage meets Level IV is entered four times and one at Level I once. The level comes from the salary against DOL's wage data for the occupation and area, not from the job title, so a modest research-associate salary in an expensive hub may count as Level I.
Before you accept, check that the company is enrolled in E-Verify (needed for STEM OPT), whether it has any H-1B history in the Data Hub, and whether it has immigration counsel who will register you. Our pre-offer startup sponsorship checklist covers the rest, and the biotech and life sciences H-1B sponsorship guide explains which lab and research roles usually qualify as specialty occupations.
The $100,000 fee and the 91% drop: a correction
Common misconception: "Universities and research institutes stopped sponsoring H-1Bs after the $100,000 fee."
Correction: The Congressional Research Service reported on 2026-10-14 that "during the first eight months that the fee was in effect, the number of initial H-1B petitions that DHS received for consular processing from cap-exempt employers dropped 91% from the same period the year before" (CRS Insight IN12747). CRS frames it as filings "for H-1B workers coming from abroad", across all cap-exempt employers rather than labs alone. It does not measure changes of status for people already here on OPT, which the fee never covered when USCIS grants them. As of 2026-11-01 the payment is blocked, and cap-exempt employers can still file.
The pipeline is thinning too. According to AAU, whose fall 2026 figures cover 55 member universities, international PhD applications fell 21% while domestic applications rose 3% (AAU; reported figures). That is an admissions number, not a hiring number.
Worked timeline: one PhD, two offers
Say you hold a US PhD in a STEM field, your OPT EAD runs 2026-07-01 to 2027-06-30, and in November 2026 you have two offers: a Boston university postdoc and a San Diego company scientist role.
| When | Offer A: university postdoc (cap-exempt) | Offer B: company scientist (cap-subject) |
|---|---|---|
| Nov 2026 to early 2027 | The university files the labor condition application, then a cap-exempt I-129 requesting a change of status | You start on OPT; confirm E-Verify enrollment and who signs Form I-983 |
| Spring 2027 | Approval can come any time; premium processing was 15 business days for most I-129s as of 2026-11-01 | FY2028 registration is expected around March 2027 but not announced; USCIS must give at least 30 days' notice |
| By 2027-06-30 | No cap-gap: work continues without a break only if the H-1B is approved and starts by the time the EAD ends | A STEM OPT I-765 filed before the EAD expires carries the 180-day automatic extension; one filed after it expires does not |
| From 2027-07-01 | Without approval, OPT work stops when the EAD ends; ask your DSO how the F-1 60-day grace period applies | You keep working on the STEM OPT extension; if selected, the H-1B can start 2027-10-01 (FY2028) |
| If plans change | A later move to industry generally means the lottery unless already counted | Not selected: STEM OPT can run to 2029-06-30 (150 days of total unemployment), leaving room for another registration season |
For Offer A, STEM OPT is also open with a university employer that is enrolled in E-Verify and signs Form I-983, which can keep work authorization running while a late cap-exempt petition is pending; whether that fits your dates is a question for your DSO. The F-1 60-day grace period still applies because the Duration of Status rule has been blocked by a federal court since 2026-09-14 (summary judgment briefed; DHS's appeal pending); you cannot work during it. Premium-processing terms are on the USCIS premium processing page. A USCIS draft rule titled "Amending the Premium Processing Timeframe" (RIN 1615-AD25) has been under OIRA review since 2026-10-13; no text is public and today's timeframes apply. The FY2028 notice will appear on the H-1B registration page.
Which biotech hub is best for international students?
No single city wins; the right hub matches your degree and your timeline.
- PhD who wants to skip the lottery: weight cap-exempt depth in Boston, Maryland, the Bay Area (UCSF), Philadelphia (Penn) and the Research Triangle (Duke, UNC).
- Biostatistics, clinical data or regulatory: CRO and pharma filers in Durham and central New Jersey.
- Drug discovery and therapeutics: Boston-Cambridge (Moderna, Vertex, Biogen), Maryland (AstraZeneca, Alexion), Princeton (Bristol Myers Squibb) and the South San Francisco and Foster City cluster (Genentech, Gilead).
- Genomics tools, devices or instruments: San Diego (Illumina, Dexcom) and Boston (Thermo Fisher).
- Public university in Texas or Florida: check the state freeze first.
Cost and the lottery. Boston, the Bay Area and San Diego are among the most expensive hubs to live in, and prevailing wages there tend to run higher too. That matters twice for a company offer: the employer must pay at least the prevailing wage for the job and area, and the registration page weights selection by "the highest OEWS wage level" your offered wage meets. Our reading: the same salary can reach a higher wage level in a lower-wage metro than in Boston or the Bay Area. Universities, their affiliated nonprofits and nonprofit or government research organizations use a separate "ACWIA - Higher Education" wage set instead of the All Industries one (DOL FLAG FAQ), so ask a lab which set applies to your offer and look up both before you compare salaries across hubs.
How to compare biotech hubs for your own search
- Open the USCIS H-1B Employer Data Hub and search each target employer by name and city, noting initial versus continuing approvals.
- Scan our hub pages for Boston, San Diego, Durham and Maryland to see which employers file most, then open each company page for its year-by-year split.
- Ask each lab's HR team or international scholars office whether it files cap-exempt for your role and uses premium processing (Form I-907).
- Check E-Verify enrollment before a STEM OPT offer with our guide to checking any company's E-Verify status, and ask who signs Form I-983.
- Look up prevailing wages and wage levels for your occupation and area on DOL's OFLC wage search, and past LCA filings on DOL's OFLC performance data page.
- Book your DSO for OPT, STEM OPT and grace-period dates, and ask the employer's immigration attorney about petition timing.
Common mistakes
- Reading a metro total as a biotech count. The Bay Area, Durham, San Diego and Maryland totals are mostly tech and IT filers.
- Assuming everything near a university is cap-exempt. The employer must qualify, or you must spend at least half your time at a qualifying entity.
- Expecting cap-gap on a university H-1B. There is none, so a late approval means a break in work.
- Treating a postdoc H-1B as lottery insurance. A later company job is generally cap-subject unless you were already counted.
- Reading the 91% drop as a ban. It measured consular-processing petitions; the payment is blocked as of 2026-11-01.
- Taking a STEM OPT offer without checking E-Verify. No enrollment, no STEM OPT with that employer.
Frequently asked questions
What are the biggest biotech hubs in the US?
For international scientists: Boston-Cambridge, the San Francisco Bay Area, San Diego, Maryland's I-270 corridor, Princeton, the Research Triangle and Philadelphia. The Bay Area has the most H-1B filers in the Data Hub extract we use (357 employers and 96,313 petition decisions, FY2024 through FY2026, FY2026 partial), but that covers every industry, so compare each hub's life-science employers instead.
Which biotech hub is best for international students?
The one whose employers fit your degree and visa timeline. A PhD avoiding the lottery gains most where cap-exempt employers are large (Boston; Maryland's NIH, HHMI and Johns Hopkins; the Bay Area's UCSF; Philadelphia's Penn). An industry-bound graduate should count the cap-subject companies that file there. As of November 1, 2026, cap-exempt employers can still file year-round without the lottery.
Do biotech startups sponsor H-1B?
Some do, but the petition is usually cap-subject, so you need a lottery selection, weighted by wage level since 2026-02-27 (Level IV four times, Level I once). For STEM OPT the startup must be enrolled in E-Verify and sign Form I-983. Check its filing history in the Data Hub before you accept.
Are academic research jobs in biotech hubs cap-exempt?
Often, because the employer type decides it, not the job title. Universities, their affiliated or related nonprofits, nonprofit research organizations and government research organizations can file cap-exempt petitions year-round, under definitions revised effective 2025-01-17. There is no cap-gap, so the H-1B needs approval before your OPT EAD ends to avoid a break in work, and a later company job generally means the lottery unless you were already counted.
Is the Maryland I-270 corridor a real biotech hub?
Yes. In our extract (FY2024 through FY2026, FY2026 partial), Maryland's life-science filers along and near I-270 include NIH (491 decisions), AstraZeneca (234), HHMI (123 and 121 under two names) and Alexion (102). IT-services firms supply most of the state's 20,047 total, so judge the corridor by these employers.
Sources
- USCIS, H-1B Employer Data Hub
- USCIS, H-1B Specialty Occupations
- USCIS, Cap-gap extension of OPT and F-1 status
- USCIS, STEM OPT extension
- USCIS, Form I-129, H-1B electronic registration and premium processing
- Congressional Research Service, Insight IN12747 (2026-10-14)
- Federal Register, Proclamation 11069
- Reginfo.gov, RIN 1615-AD00
- Reginfo.gov, RIN 1615-AD25 review
- DOL, OFLC wage search, FLAG FAQ and OFLC performance data
- AAU, PhD admissions data
- Central Florida Public Media (Florida) and FOX 7 Austin (Texas)
How we checked this: on 2026-11-01 and 2026-11-02 we read the USCIS Data Hub, H-1B, cap-gap, STEM OPT, I-129, registration and premium-processing pages and the text of CRS Insight IN12747, checked fee, rules-pipeline and state-freeze status against the Federal Register, reginfo.gov and news reports, read DOL's FLAG FAQ on ACWIA wage data, and took every employer and hub count from the USCIS Employer Data Hub extract behind our company pages.
This is general information, not legal or tax advice. Your own I-20, EAD, I-94 and USCIS notices govern; talk to your DSO about F-1, OPT or SEVIS questions and to a licensed immigration attorney about petitions and status strategy.
If you are weighing labs and companies across these hubs while your OPT clock runs, F1Jobs can help you build a focused search around employers with a real sponsorship track record.
Frequently asked questions
What are the biggest biotech hubs in the US?
For international scientists, the main ones are Boston-Cambridge, the San Francisco Bay Area, San Diego, Maryland's I-270 corridor, Princeton, the Research Triangle and Philadelphia. The Bay Area has the most H-1B filers in the USCIS Employer Data Hub extract we use (357 employers and 96,313 petition decisions, FY2024 through FY2026, FY2026 partial), but that total covers every industry, so compare each hub's life-science employers instead.
Which biotech hub is best for international students?
The one whose employers fit your degree and visa timeline. A PhD who wants to avoid the H-1B lottery gains most where cap-exempt research employers are large, such as Boston, Maryland (NIH, HHMI, Johns Hopkins), the Bay Area (UCSF) and Philadelphia (Penn). An industry-bound graduate should count the cap-subject companies that actually file there. As of November 1, 2026, cap-exempt employers can still file year-round without the lottery.
Do biotech startups sponsor H-1B?
Some do, but a startup's petition is usually cap-subject, so you need a lottery selection first, and since 2026-02-27 the lottery weights entries by wage level (Level IV four times, Level I once). For STEM OPT the startup must be enrolled in E-Verify and sign Form I-983. Check its filing history in the USCIS H-1B Employer Data Hub before you accept.
Are academic research jobs in biotech hubs cap-exempt?
Often, because the employer type decides it, not the job title. Universities, their affiliated or related nonprofits, nonprofit research organizations and government research organizations can file cap-exempt H-1B petitions year-round, under definitions revised effective 2025-01-17. Cap-exempt petitions get no cap-gap, so the H-1B needs approval before your OPT EAD ends to avoid a break in work, and a later move to a company generally means the lottery unless you were already counted.
Is the Maryland I-270 corridor a real biotech hub?
Yes. In the extract we use (FY2024 through FY2026, FY2026 partial), Maryland's life-science filers along and near I-270 include NIH (491 petition decisions), AstraZeneca (234), the Howard Hughes Medical Institute (123 and 121 under two filer names) and Alexion (102). Most of the state's 20,047 decisions come from IT-services firms, so judge the corridor by these employers.